Please be advised that you are now leaving the Werfen website. Links are provided as a convenience and for informational purposes only. Werfen bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.
News
Stay up to date with Werfen
Autoimmunity
August 11, 2016 - San Diego, USA & Dortmund, Germany
Protagen Inks License Agreement with Inova Diagnostics for its proprietary BICD2 Biomarker